Essential roles of VLA-4 in the hematopoietic system

被引:0
|
作者
Yoichi Imai
Motomu Shimaoka
Mineo Kurokawa
机构
[1] University of Tokyo,Department of Hematology and Oncology, Graduate School of Medicine
[2] Harvard Medical School,Immune Disease Institute, Children’s Hospital Boston
来源
关键词
Integrin; VLA-4; Hematopoiesis; Chemotherapy sensitivity; Mobilization;
D O I
暂无
中图分类号
学科分类号
摘要
Integrins are one of the major families of adhesion molecules and make various kinds of biological effects by mediating cell–cell and cell–matrix interactions. Among integrins, VLA-4 is expressed on many types of hematopoietic cells including stem/progenitor cells and it is considered as a critical regulator of adult hematopoiesis. Recent studies revealed that VLA-4 is not necessarily required for the development or maintenance of adult hematopoietic cells. On the other hand, it was proved that VLA-4 is essential for homeostasis of distribution of hematopoietic stem/progenitor cells (HSPCs) and mature lymphocytes in the body. The dynamic regulation of VLA-4 function is mediated by its conformational change, which is strictly linked to the interaction between α and β cytoplasmic domains. The study using knockin mice showed that GFFKR sequence, a well-preserved motif in the α cytoplasmic domain of VLA-4, is critical for binding of α and β cytoplasmic domains as well as regulation of hematopoietic cell distribution. Small molecules targeting this cytoplasmic interaction or ligand–VLA-4 interaction may become good candidates of new drugs for mobilization of hematopoietic stem cells. Several studies have suggested the impact of VLA-4 on chemotherapy sensitivity and prognosis in hematological malignancies, which awaits further investigations.
引用
收藏
页码:569 / 575
页数:6
相关论文
共 50 条
  • [31] BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells
    Ramirez, Pablo
    Rettig, Michael P.
    Uy, Geoffrey L.
    Deych, Elena
    Holt, Matthew S.
    Ritchey, Julie K.
    DiPersio, John F.
    BLOOD, 2009, 114 (07) : 1340 - 1343
  • [32] VLA-4 INTEGRIN ON SARCOMA CELL-LINES RECOGNIZES ENDOTHELIAL VCAM-1 - DIFFERENTIAL REGULATION OF THE VLA-4 AVIDITY
    MATTILA, P
    MAJURI, ML
    RENKONEN, R
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 339 - 339
  • [33] Targeting Vla-4 reduces cell adhesion mediated drug resistance in chronic lymphocytic leukemia: Rationale for anti Vla-4 therapy
    Nowakowski, GS
    Witzig, TE
    Bone, ND
    Lee, YK
    Shanafelt, TD
    Kay, NE
    BLOOD, 2005, 106 (11) : 345A - 345A
  • [34] Apoptotic Death of Hematopoietic Tumor Cells through Potentiated and Sustained Adhesion to Fibronectin via VLA-4
    Saito, Yohei
    Owaki, Toshiyuki
    Matsunaga, Takuya
    Saze, Mizue
    Miura, Shogo
    Maeda, Mao
    Eguchi, Mayu
    Tanaka, Rika
    Taira, Junichi
    Kodama, Hiroaki
    Goto, Sumio
    Niitsu, Yoshiroh
    Terada, Hiroshi
    Fukai, Fumio
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (10) : 7006 - 7015
  • [35] MODULATION OF VLA-4 EXPRESSION ON CD4+ LYMPHOCYTES
    HUGHES, M
    SEWELL, W
    BLACK, J
    ARMOUR, C
    JOURNAL OF LEUKOCYTE BIOLOGY, 1993, : 128 - 128
  • [36] Inhibitors of integrin alpha 4 beta 1 (VLA-4)
    Adams, SP
    Lobb, RR
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 34, 1999, 34 : 179 - 188
  • [37] Squaric acid derivatives as VLA-4 integrin antagonists
    Porter, JR
    Archibald, SC
    Childs, K
    Critchley, D
    Head, JC
    Linsley, JM
    Parton, TAH
    Robinson, MK
    Shock, A
    Taylor, RJ
    Warrellow, GJ
    Alexander, RP
    Langham, B
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (07) : 1051 - 1054
  • [38] Role of VLA-4 in the development of allergic conjunctivitis in mice
    Fukushima, A
    Yamaguchi, T
    Ishida, W
    Fukata, K
    Ueno, H
    MOLECULAR VISION, 2006, 12 (32-34): : 310 - 317
  • [39] Amidines as amide bond replacements in VLA-4 antagonists
    Kamenecka, TM
    Park, YJ
    Lin, LS
    de Laszlo, S
    McCauley, ED
    Van Riper, G
    Egger, L
    Kidambi, U
    Mumford, RA
    Tong, S
    Tang, W
    Colletti, A
    Teffera, Y
    Stearns, R
    MacCross, M
    Schmidt, JA
    Hagmann, WK
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (09) : 2323 - 2326
  • [40] Design and synthesis of VLA-4/VCAM antagonists.
    Huryn, DM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U34 - U34